Stock Events

Chongkundang 

₩55,500
1
+₩0+0% Today

Statistics

Day High
55,700
Day Low
54,900
52W High
64,300
52W Low
45,400
Volume
1,865
Avg. Volume
2,653
Mkt Cap
-
P/E Ratio
-
Dividend Yield
2.52%
Dividend
1,400

Upcoming

Dividends

2.52%Dividend Yield
10Y Growth
7.18%
5Y Growth
1.49%
3Y Growth
N/A
1Y Growth
N/A

Earnings

13MayConfirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2023
Q1 2024
-725.88
-284.78
156.32
597.41
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 001630.KQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
Show more...
CEO
Mr. Young-Joo Kim
Employees
2335
Country
South Korea
ISIN
KR7001630003

Listings